(), Peter Lindgren
, Olof Johnell
and Bengt Jönsson
Niklas Zethraeus: Dept. of Economics, Stockholm School of Economics, Postal: P.O. Box 6501, SE-113 83 Stockholm, Sweden
Peter Lindgren: Dept. of Economics, Stockholm School of Economics, Postal: P.O. Box 6501, SE-113 83 Stockholm, Sweden
Olof Johnell: Department of Orthopaedics, Postal: Universitetssjukhuset Mas, SE-205 02 Malmö, Sweden
Bengt Jönsson: Dept. of Economics, Stockholm School of Economics, Postal: P.O. Box 6501, SE-113 83 Stockholm, Sweden
Abstract: This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality are included. The report describes the model's structure and data requirements; it also investigates the impact on the CE results by using the new model and by adding the wrist and spine fractures to the model. We further investigate whether the results are sensitive to the inclusion of Swedish risk and mortality data for CHD instead of using data based on the Framingham study. The results show that the incremental cost-effectiveness ratios (ICERs) are insensitive to the chosen model, to the assumption that the risk of wrist and spine fracture follows that of hip fracture, and to replacing the Framingham data with Swedish CHD risk and mortality data.
57 pages, March 20, 2000
Full text files
hastef0368.pdf.zip Full text
hastef0368.pdf Full text
hastef0368.ps.zip PostScript file Full text
hastef0368.ps PostScript file Full text
Questions (including download problems) about the papers in this series should be directed to Helena Lundin ()
Report other problems with accessing this service to Sune Karlsson ().
This page generated on 2018-03-27 10:24:48.